Compare BIO & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | GATX |
|---|---|---|
| Founded | 1952 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Transportation Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.2B |
| IPO Year | N/A | 1994 |
| Metric | BIO | GATX |
|---|---|---|
| Price | $278.96 | $183.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $358.50 | $215.00 |
| AVG Volume (30 Days) | ★ 289.2K | 182.6K |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ 17.22 |
| EPS | N/A | ★ 9.12 |
| Revenue | N/A | ★ $1,740,400,000.00 |
| Revenue This Year | $2.31 | $39.80 |
| Revenue Next Year | $3.10 | $3.49 |
| P/E Ratio | ★ $9.72 | $20.59 |
| Revenue Growth | N/A | ★ 9.77 |
| 52 Week Low | $211.43 | $139.44 |
| 52 Week High | $343.12 | $199.00 |
| Indicator | BIO | GATX |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 44.38 |
| Support Level | $266.71 | $179.71 |
| Resistance Level | $290.01 | $186.61 |
| Average True Range (ATR) | 9.32 | 4.91 |
| MACD | 0.34 | -1.17 |
| Stochastic Oscillator | 57.28 | 10.46 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.